Status:
UNKNOWN
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Lead Sponsor:
Region Skane
Conditions:
Prostate Cancer (Diagnosis)
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
Patient-blinded randomized controlled trial evaluating length and quality of prostate biopsies taken by a novel biopsy needle.
Detailed Description
Prostate biopsy is the golden standard for prostate cancer diagnosis. Transrectal prostate biopsy (TRUSbx) is the most widely used technique. The biopsy chamber of the Tru Cut needle is in general 19 ...
Eligibility Criteria
Inclusion
- Eligible for prostate biopsy
- Signed informed written consent
Exclusion
- \- None (other than general contraindications for prostate biopsy or patient not willing to participate)
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04880681
Start Date
May 17 2021
End Date
February 28 2024
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsingborg Hospital
Helsingborg, Skåne County, Sweden, 254 37